Today: 11 June 2026
Palantir stock slides 5.6% to start 2026 as traders reassess pricey AI plays
3 January 2026
2 mins read

Palantir stock slides 5.6% to start 2026 as traders reassess pricey AI plays

NEW YORK, January 3, 2026, 03:48 ET — Market closed

  • Palantir shares fell about 5.6% on the first trading day of 2026, lagging the broader market.
  • Trading was heavy as money rotated toward chipmakers and away from software, according to market commentary.
  • Investors are now looking to the next earnings timing and key U.S. data for fresh direction.

Palantir Technologies Inc (PLTR) shares fell about 5.6% on Friday, the first U.S. trading day of 2026, and last traded at $167.86. The stock ranged from $166.38 to $182.93 on volume of about 60.6 million shares.

The drop matters because investors are starting the year by stress-testing the AI trade, separating infrastructure winners from software names that have rallied hard. Palantir has become a popular proxy for that debate.

Early-year positioning can exaggerate moves, especially in high-growth stocks. When traders reduce risk, they often sell the names that ran the most.

A Nasdaq.com column said there was no company-specific news driving the move, pointing instead to a “rotation” — investors shifting money — out of software and into semiconductor stocks. It also cited profit-taking, when investors sell winners to lock in gains, as positioning resets for the new year. Nasdaq

Broader markets were mixed: the Dow and S&P 500 ended higher on Friday while the Nasdaq was flat, Reuters reported. The Philadelphia SE Semiconductor index jumped 4% as Nvidia and Intel gained, and Tesla slid 2.6% after annual sales fell for a second year. “Investors might be a little bit more conscious about some of the valuations that they’re paying for some of the AI plays,” said Joe Mazzola, head of trading and derivatives strategist at Charles Schwab. Reuters

That backdrop matters for Palantir because the stock has been treated as a bet on the commercialization of generative AI — systems that can create text, code or images from prompts. Rotations toward chips and away from software can hit sentiment-driven names quickly.

Palantir sells data-analysis software used by governments and businesses, and demand has been boosted by wider adoption of artificial intelligence, the company has said. The stock’s valuation has drawn repeated debate as growth expectations reset from quarter to quarter.

On the technical side, TipRanks said Palantir is trading around its 50-day moving average — a commonly watched trend line — with the level near $181.20. TipRanks also showed a consensus Hold rating and an average price target of $187.87.

Before the next U.S. session on Monday, investors will be watching whether the shares stabilize above Friday’s low or extend the pullback. A steadier tape could bring dip-buyers back; another sharp leg down would keep the focus on risk controls.

The next clear company catalyst is earnings. Wall Street Horizon lists Palantir’s next report for Monday, Feb. 2, after the market close, but says the date is unconfirmed by the company.

Macro events will also shape appetite for high-growth software. Stocks whose value depends on profits further out — often called “long-duration” stocks — tend to react most when interest-rate expectations change.

Stock Market Today

  • Sigma Healthcare's Valuation Reassessed After Recent Share Price Declines
    June 11, 2026, 4:09 PM EDT. Sigma Healthcare (ASX:SIG) shares have declined 7.6% over the past week and 15.5% over the past year but exhibit strong long-term gains with a 231.7% return over three years. The stock currently trades at A$2.69, slightly below Simply Wall St's discounted cash flow (DCF) valuation of A$2.81 per share, indicating it is roughly fairly valued with a 4.1% discount. Despite short-term price weakness, Sigma Healthcare scores 2 out of 6 on valuation metrics, suggesting mixed signals on undervaluation. Its free cash flow is projected to increase substantially through 2028, supporting the fair value estimate. Investors are balancing recent price softness with long-term fundamentals amid ongoing reassessments of risk and return in Australia's healthcare supply chain sector.

Latest articles

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

11 June 2026
Coeur Mining surged 5.2% to $16.205 on heavy volume as investors positioned ahead of its S&P MidCap 400 addition effective June 22, following recent acquisitions and a sector-wide rally in precious-metals stocks; the company’s market cap hit $16.76 billion, with index inclusion and recent financial results drawing institutional attention.
Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

11 June 2026
Trump Media, TAE Technologies and Texas Ventures Acquisition III have scrapped plans to spin off Truth Social and other media assets, keeping them within Trump Media as it pursues a merger with TAE; DJT shares traded at $8.03 Thursday after falling over 38% this year, with the next key event being the merger filing process and SEC registration.
Shopify stock slides after Canadian court order in CRA data dispute
Previous Story

Shopify stock slides after Canadian court order in CRA data dispute

Carvana stock drops 5% after insider sale filings; what CVNA investors watch next week
Next Story

Carvana stock drops 5% after insider sale filings; what CVNA investors watch next week

Go toTop